Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective
This comprehensive review offers a detailed look at atopic dermatitis (AD) treatment in Italy, focusing primarily on the use of biologics and small molecules. In response to advancing knowledge of AD's causes and treatments, there's a global need for updated guidelines to provide physicia...
Main Authors: | Alba Guglielmo, Maria Ludovica Deotto, Luigi Naldi, Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2023-09-01
|
Series: | Dermatology Reports |
Subjects: | |
Online Access: | https://www.pagepress.org/journals/index.php/dr/article/view/9839 |
Similar Items
-
Baricitinib for the treatment of atopic dermatitis
by: Amelia Melo, et al.
Published: (2022-07-01) -
Real‐life case‐series experience with tralokinumab in patients with severe atopic dermatitis
by: Francesca Caroppo, et al.
Published: (2024-03-01) -
JAK/STAT inhibitors for the treatment of atopic dermatitis
by: Maria Alexandra Rodrigues, et al.
Published: (2020-01-01) -
Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis
by: Helena Iznardo, et al.
Published: (2023-01-01) -
Treatment of Atopic Dermatitis with Baricitinib: First Real-life Experience
by: Danielle Rogner, et al.
Published: (2022-03-01)